| COVID-19 |
1 |
1 |
| Child |
0 |
0.99 |
| Acute Respiratory Distress Syndrome |
0 |
0.39 |
| Severe Acute Respiratory Syndrome |
0 |
0.95 |
| COVID-19 Vaccine |
0 |
0.8 |
| Vaccines |
0 |
0.75 |
| Adolescent Medicine |
0 |
0.18 |
| Pediatric Respiratory Infections |
0 |
0.17 |
| Tdap Vaccine |
0 |
0.17 |
| Grant |
0 |
0.11 |
| Immunization |
0 |
0.07 |
| California |
0 |
0.04 |
| Canada |
0 |
0.04 |
| Caregiver |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Food and Drug Administration (FDA) |
0 |
0.04 |
| Hand |
0 |
0.04 |
| Health Care Quality, Access, and Evaluation |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Pandemic |
0 |
0.04 |
| Pedal |
0 |
0.04 |
| Pertussis |
0 |
0.04 |
| Tennessee |
0 |
0.04 |
| Utah |
0 |
0.04 |
| Influenza |
0 |
0.03 |
| Social Determinants of Health |
0 |
0.03 |